Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cefmetazole
2. Cefmetazole Monosodium Salt
3. Cefmetazon
4. Cs 1170
5. Cs-1170
6. Cs1170
7. Monosodium Salt, Cefmetazole
8. Salt, Cefmetazole Monosodium
9. Sodium, Cefmetazole
10. U 72791a
11. U-72791a
12. U72791a
13. Zefazone
1. 56796-39-5
2. Zefazone
3. Cefmetazole Sodium Salt
4. Cefmetazon
5. Cmz Sodium
6. Cs 1170 Sodium
7. Skf 83088 Sodium
8. Cefmetazole (sodium)
9. Cefmetazone
10. Chebi:3490
11. Metafar
12. U-72791a
13. 37y9vr4w7a
14. Sodium Cefmetazole
15. Nsc-758171
16. Sodium (6r,7s)-7-(2-((cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
17. Dsstox_cid_25590
18. Dsstox_rid_80985
19. Dsstox_gsid_45590
20. Cmz
21. Sodium;(6r,7s)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
22. Zefazone In Plastic Container
23. U 72791a
24. Unii-37y9vr4w7a
25. Prestwick_21
26. Ncgc00017120-01
27. Zefazone (tn)
28. Sodium (6r,7s)-7-(2-((cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
29. Cefmetazole Sodium [usan:usp:jan]
30. Cas-56796-39-5
31. Mfcd00214260
32. Epitope Id:116656
33. Mls000028660
34. Schembl193751
35. Chembl1201118
36. Dtxsid5045590
37. Cefmetazole Sodium (jp17/usp)
38. Cefmetazole Sodium [usan]
39. Cefmetazole Sodium [vandf]
40. Hms1570k21
41. Hms2097k21
42. Hms2230g19
43. Hms3260f14
44. Hms3714k21
45. Cefmetazole Sodium [mart.]
46. Bcp11979
47. Cefmetazole Sodium [who-dd]
48. Hy-b1257
49. Tox21_110788
50. Tox21_500266
51. Cefmetazole Sodium Salt [mi]
52. Akos025392167
53. Tox21_110788_1
54. Ccg-220700
55. Ccg-221570
56. Cs-4966
57. Ks-1415
58. Lp00266
59. Nsc 758171
60. Cefmetazole Sodium [orange Book]
61. Ncgc00023016-07
62. Ncgc00093724-01
63. Ncgc00260951-01
64. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-((((cyanomethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, Monosodium Salt, (6r-cis)-
65. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-((((cyanomethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, Sodium Salt, (6r-cis)-
66. Cefmetazole Sodium [usp Monograph]
67. Smr000058923
68. Sodium (6r,7s)-7-(2-(cyanomethylthio)acetamido)-7-methoxy-3-((1-methyl-1h-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
69. Sodium (6r,7s)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
70. Cs-1170; Skf-83088
71. Eu-0100266
72. C 6048
73. C-2472
74. C08104
75. C75664
76. D00911
77. A831179
78. Q27106105
79. Cefmetazole Sodium Salt, Antibiotic For Culture Media Use Only
80. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-((((cyanomethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, Monosodium Salt, (6r-cis)
81. Sodium (6r,7s)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanyl
82. Sodium 6beta-{[(cyanomethyl)sulfanyl]acetamido}-6alpha-methoxy-3-{[(1-methyl-1h-tetrazol-5-yl)sulfanyl]methyl}ceph-3-em-4-carboxylate
Molecular Weight | 493.5 g/mol |
---|---|
Molecular Formula | C15H16N7NaO5S3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 9 |
Exact Mass | 493.02727444 g/mol |
Monoisotopic Mass | 493.02727444 g/mol |
Topological Polar Surface Area | 242 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 824 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Market Place
ABOUT THIS PAGE
A Cefmetazole Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cefmetazole Sodium, including repackagers and relabelers. The FDA regulates Cefmetazole Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cefmetazole Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cefmetazole Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cefmetazole Sodium supplier is an individual or a company that provides Cefmetazole Sodium active pharmaceutical ingredient (API) or Cefmetazole Sodium finished formulations upon request. The Cefmetazole Sodium suppliers may include Cefmetazole Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Cefmetazole Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cefmetazole Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Cefmetazole Sodium active pharmaceutical ingredient (API) in detail. Different forms of Cefmetazole Sodium DMFs exist exist since differing nations have different regulations, such as Cefmetazole Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cefmetazole Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Cefmetazole Sodium USDMF includes data on Cefmetazole Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cefmetazole Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cefmetazole Sodium suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cefmetazole Sodium Drug Master File in Japan (Cefmetazole Sodium JDMF) empowers Cefmetazole Sodium API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cefmetazole Sodium JDMF during the approval evaluation for pharmaceutical products. At the time of Cefmetazole Sodium JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cefmetazole Sodium suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cefmetazole Sodium Drug Master File in Korea (Cefmetazole Sodium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cefmetazole Sodium. The MFDS reviews the Cefmetazole Sodium KDMF as part of the drug registration process and uses the information provided in the Cefmetazole Sodium KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cefmetazole Sodium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cefmetazole Sodium API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cefmetazole Sodium suppliers with KDMF on PharmaCompass.
Cefmetazole Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cefmetazole Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cefmetazole Sodium GMP manufacturer or Cefmetazole Sodium GMP API supplier for your needs.
A Cefmetazole Sodium CoA (Certificate of Analysis) is a formal document that attests to Cefmetazole Sodium's compliance with Cefmetazole Sodium specifications and serves as a tool for batch-level quality control.
Cefmetazole Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Cefmetazole Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cefmetazole Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Cefmetazole Sodium EP), Cefmetazole Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cefmetazole Sodium USP).
LOOKING FOR A SUPPLIER?